Annual Accounts Receivable
$241.39 M
+$22.93 M+10.49%
30 June 2024
Summary:
Bio-Techne annual accounts receivable is currently $241.39 million, with the most recent change of +$22.93 million (+10.49%) on 30 June 2024. During the last 3 years, it has risen by +$96.01 million (+66.04%). TECH annual accounts receivable is now at all-time high.TECH Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$223.69 M
-$17.71 M-7.33%
30 September 2024
Summary:
Bio-Techne quarterly accounts receivable is currently $223.69 million, with the most recent change of -$17.71 million (-7.33%) on 30 September 2024. Over the past year, it has increased by +$16.24 million (+7.83%). TECH quarterly accounts receivable is now -7.33% below its all-time high of $241.39 million, reached on 30 June 2024.TECH Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TECH Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.5% | +7.8% |
| 3 y3 years | +66.0% | +46.3% |
| 5 y5 years | +75.6% | +100.2% |
TECH Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +66.0% | -7.3% | +46.3% |
| 5 y | 5 years | at high | +97.0% | -7.3% | +100.2% |
| alltime | all time | at high | +1418.8% | -7.3% | +1432.6% |
Bio-Techne Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $223.69 M(-7.3%) |
| June 2024 | $241.39 M(+10.5%) | $241.39 M(+5.9%) |
| Mar 2024 | - | $227.89 M(+9.9%) |
| Dec 2023 | - | $207.45 M(+1.4%) |
| Sept 2023 | - | $204.57 M(-6.4%) |
| June 2023 | $218.47 M(+12.3%) | $218.47 M(+0.9%) |
| Mar 2023 | - | $216.41 M(+17.1%) |
| Dec 2022 | - | $184.76 M(+6.1%) |
| Sept 2022 | - | $174.17 M(-10.5%) |
| June 2022 | $194.55 M(+33.8%) | $194.55 M(-3.7%) |
| Mar 2022 | - | $202.09 M(+32.2%) |
| Dec 2021 | - | $152.90 M(+3.6%) |
| Sept 2021 | - | $147.55 M(+1.5%) |
| June 2021 | $145.38 M(+18.6%) | $145.38 M(-7.9%) |
| Mar 2021 | - | $157.79 M(+23.0%) |
| Dec 2020 | - | $128.24 M(+4.6%) |
| Sept 2020 | - | $122.64 M(+0.1%) |
| June 2020 | $122.53 M(-10.9%) | $122.53 M(+4.3%) |
| Mar 2020 | - | $117.45 M(+5.1%) |
| Dec 2019 | - | $111.75 M(-8.9%) |
| Sept 2019 | - | $122.72 M(-10.7%) |
| June 2019 | $137.47 M(+14.3%) | $137.47 M(+2.6%) |
| Mar 2019 | - | $133.93 M(+18.2%) |
| Dec 2018 | - | $113.28 M(-1.3%) |
| Sept 2018 | - | $114.75 M(-4.6%) |
| June 2018 | $120.30 M(+3.0%) | $120.30 M(+9.6%) |
| Mar 2018 | - | $109.76 M(+11.4%) |
| Dec 2017 | - | $98.50 M(-8.2%) |
| Sept 2017 | - | $107.33 M(-8.1%) |
| June 2017 | $116.83 M(+25.1%) | $116.83 M(-1.3%) |
| Mar 2017 | - | $118.33 M(+13.4%) |
| Dec 2016 | - | $104.37 M(-5.0%) |
| Sept 2016 | - | $109.81 M(+17.6%) |
| June 2016 | $93.39 M(+33.4%) | $93.39 M(+7.2%) |
| Mar 2016 | - | $87.16 M(+31.8%) |
| Dec 2015 | - | $66.14 M(-6.7%) |
| Sept 2015 | - | $70.92 M(+1.3%) |
| June 2015 | $70.03 M(+27.3%) | $70.03 M(+6.3%) |
| Mar 2015 | - | $65.89 M(+15.2%) |
| Dec 2014 | - | $57.21 M(-6.0%) |
| Sept 2014 | - | $60.87 M(+10.7%) |
| June 2014 | $55.00 M(+44.0%) | $55.00 M(+13.4%) |
| Mar 2014 | - | $48.50 M(+26.6%) |
| Dec 2013 | - | $38.31 M(-9.3%) |
| Sept 2013 | - | $42.24 M(+10.6%) |
| June 2013 | $38.18 M | $38.18 M(+0.1%) |
| Mar 2013 | - | $38.14 M(+18.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | $32.19 M(-8.3%) |
| Sept 2012 | - | $35.12 M(-1.5%) |
| June 2012 | $35.67 M(-0.7%) | $35.67 M(-8.8%) |
| Mar 2012 | - | $39.11 M(+20.9%) |
| Dec 2011 | - | $32.35 M(-5.1%) |
| Sept 2011 | - | $34.09 M(-5.1%) |
| June 2011 | $35.91 M(+16.4%) | $35.91 M(+1.0%) |
| Mar 2011 | - | $35.55 M(+26.0%) |
| Dec 2010 | - | $28.23 M(-9.0%) |
| Sept 2010 | - | $31.02 M(+0.5%) |
| June 2010 | $30.85 M(+4.5%) | $30.85 M(-10.6%) |
| Mar 2010 | - | $34.53 M(+32.0%) |
| Dec 2009 | - | $26.16 M(-13.8%) |
| Sept 2009 | - | $30.33 M(+2.8%) |
| June 2009 | $29.52 M(-7.0%) | $29.52 M(-6.6%) |
| Mar 2009 | - | $31.59 M(+27.1%) |
| Dec 2008 | - | $24.85 M(-23.0%) |
| Sept 2008 | - | $32.30 M(+1.7%) |
| June 2008 | $31.75 M(+7.4%) | $31.75 M(-3.2%) |
| Mar 2008 | - | $32.80 M(+12.0%) |
| Dec 2007 | - | $29.27 M(-4.6%) |
| Sept 2007 | - | $30.67 M(+3.8%) |
| June 2007 | $29.56 M(+24.4%) | $29.56 M(-0.1%) |
| Mar 2007 | - | $29.58 M(+29.0%) |
| Dec 2006 | - | $22.92 M(-6.3%) |
| Sept 2006 | - | $24.47 M(+2.9%) |
| June 2006 | $23.77 M(+7.8%) | $23.77 M(-8.7%) |
| Mar 2006 | - | $26.02 M(+23.8%) |
| Dec 2005 | - | $21.02 M(-6.4%) |
| Sept 2005 | - | $22.46 M(+1.9%) |
| June 2005 | $22.04 M(+8.8%) | $22.04 M(-4.3%) |
| Mar 2005 | - | $23.02 M(+22.5%) |
| Dec 2004 | - | $18.80 M(+0.5%) |
| Sept 2004 | - | $18.71 M(-7.6%) |
| June 2004 | $20.26 M(+10.2%) | $20.26 M(-1.5%) |
| Mar 2004 | - | $20.56 M(+21.3%) |
| Dec 2003 | - | $16.95 M(-5.3%) |
| Sept 2003 | - | $17.90 M(-2.6%) |
| June 2003 | $18.39 M(+8.7%) | $18.39 M(-1.9%) |
| Mar 2003 | - | $18.73 M(+26.0%) |
| Dec 2002 | - | $14.87 M(-11.1%) |
| Sept 2002 | - | $16.71 M(-1.2%) |
| June 2002 | $16.91 M(+6.4%) | $16.91 M(-1.4%) |
| Mar 2002 | - | $17.15 M(+17.5%) |
| Dec 2001 | - | $14.60 M(-11.1%) |
| Sept 2001 | - | $16.41 M(+3.2%) |
| June 2001 | $15.89 M | $15.89 M(+5.0%) |
| Mar 2001 | - | $15.14 M |
FAQ
- What is Bio-Techne annual accounts receivable?
- What is the all time high annual accounts receivable for Bio-Techne?
- What is Bio-Techne annual accounts receivable year-on-year change?
- What is Bio-Techne quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Bio-Techne?
- What is Bio-Techne quarterly accounts receivable year-on-year change?
What is Bio-Techne annual accounts receivable?
The current annual accounts receivable of TECH is $241.39 M
What is the all time high annual accounts receivable for Bio-Techne?
Bio-Techne all-time high annual accounts receivable is $241.39 M
What is Bio-Techne annual accounts receivable year-on-year change?
Over the past year, TECH annual accounts receivable has changed by +$22.93 M (+10.49%)
What is Bio-Techne quarterly accounts receivable?
The current quarterly accounts receivable of TECH is $223.69 M
What is the all time high quarterly accounts receivable for Bio-Techne?
Bio-Techne all-time high quarterly accounts receivable is $241.39 M
What is Bio-Techne quarterly accounts receivable year-on-year change?
Over the past year, TECH quarterly accounts receivable has changed by +$16.24 M (+7.83%)